Shares of Eli Lilly (LLY) are soaring after the pharmaceutical giant received regulatory approval in China for its GLP-1 weight-loss drug, Zepbound. Yahoo...
This comes about a month after Novo Nordisk weight loss therapy got approval in the country.But what do we know about the fundamental story here?
And also with no, no while there still are shortages out there, this signals that they're working on and are able to produce enough to start opening up those markets. LOS ANGELES — Former co-stars and famous fans paid tribute to comedian and actor Bob Newhart, known for his deadpan humor and the sitcoms he starred in bearing his name, after his death Thursday at age 94.
The minor gaff came at the end of her first night in Gelsenkirchen, Germany — where she is set to play two more nights this week"As you are occupied with other companions, I hereby declare our divorce," Sheikha Mahra bint Mohammed bin Rashid Al Maktoum said in a social media post Lopez was photographed in the laid-back look on July 16 as she and Ben Affleck spent their second wedding anniversary on opposite coastsThe Princess of Wales, who is undergoing cancer treatment, spoke about the "transformative" power of nature as one of her patronages made an exciting announcement
Regulatory Approval Pharmaceutical Companies China Anjalee Khemlani Pharmaceutical Giant
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Eli Lilly Broadens Crackdown on Fake and Compounded ZepboundEli Lilly & Co. broadened its effort to crack down on fake and off-brand versions of hit obesity drug Zepbound, saying it has filed more lawsuits against companies selling compounded versions of the treatment.
Read more »
Novo Nordisk, Eli Lilly still top 2 pharma stocks: AnalystNovo Nordisk (NVO) and Eli Lilly (LLY) both made headlines recently with positive drug trial results for their respective GLP-1 weight-loss drugs, as well as...
Read more »
Innovent’s Obesity Drug Shows Similar Weight Loss as Eli Lilly’sA new obesity drug co-developed by China’s Innovent Biologics Inc. and Eli Lilly & Co. has demonstrated significant weight loss in a late stage trial, paying the way for its approval in the country to compete with the blockbuster from Novo Nordisk A/S.
Read more »
WHO and Eli Lilly caution patients against falling for fake versions of popular weight-loss drugsCP24 is your source for breaking news headlines from around the world, including on the Israel-Hamas war, the India-Canada rift and the war between Russia and Ukraine.
Read more »
WHO and Eli Lilly caution patients against falling for fake versions of popular weight-loss drugsThe World Health Organization and drugmaker Eli Lilly and Co. are warning people to be wary of fake versions of popular weight-loss and diabetes medicines.
Read more »
Novo Nordisk, Eli Lilly fall on data from Roche's weight-loss pillShares of Novo Nordisk (NVO) and Eli Lilly (LLY) are sliding after Roche (ROG.SW, RBO.PA) reported promising early-stage trial data from its weight-loss pill...
Read more »